|
1 |
29 05 2026 |
NPPA fixes retail prices of 30 new drugs |
Pharmabiz |
India |
|
2 |
29 05 2026 |
Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta |
Health world (Economic Times) |
India |
|
3 |
28 05 2026 |
Indoco’s oral solid dosage manufacturing facility at Baddi receives EU CMP certification |
Pharmabiz |
India |
|
4 |
28 05 2026 |
LifeArc inks partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children |
Pharmabiz |
India |
|
5 |
28 05 2026 |
TN IDMA and Pronto Consult announce 2nd edition of Brand Impact Awards with new south India focus |
Pharmabiz |
India |
|
6 |
28 05 2026 |
Industry sees growing need for advanced AHU filter maintenance systems under revised schedule M |
Pharmabiz |
India |
|
7 |
28 05 2026 |
Brazil approves First Semaglutide Pen as EMS challenges Novo Nordisk's Ozempic |
Medical Dialogues |
Brazil |
|
8 |
28 05 2026 |
CDSCO issues revised Drug sampling guidelines to strengthen rural surveillance |
Medical Dialogues |
India |
|
9 |
28 05 2026 |
Novo Nordisk's Wegovy approved for teens in India |
Health world (Economic Times) |
India |
|
10 |
27 05 2026 |
Pharmaceuticals exports grew over 7% in April |
Pharmabiz |
India |
|
11 |
27 05 2026 |
CDSCO introduces interim measures to support applicants of PI system |
Pharmabiz |
India |
|
12 |
27 05 2026 |
Industry concerned over immediate licence cancellation on NSQ drug reports without due process |
Pharmabiz |
India |
|
13 |
27 05 2026 |
Skymap Pharma to buy state-run Indian Medicines Pharma for ₹121 cr |
Health world (Economic Times) |
India |
|
14 |
27 05 2026 |
Viridian Therapeutics signs manufacturing deal with WuXi Biologics for thyroid eye disease drug |
Health world (Economic Times) |
India |
|
15 |
27 05 2026 |
US biotech Regeneron to house GCC in Hyderabad |
Health world (Economic Times) |
India |
|
16 |
27 05 2026 |
Brazil approves first generic semaglutide pen after Ozempic patent expiry |
Health world (Economic Times) |
India |
|
17 |
27 05 2026 |
Torrent Pharma eyes India launch of MASH drug resmetirom after Semaglutide success |
Medical Dialogues |
India |
|
18 |
27 05 2026 |
DCOIWA hosts national workshop on spurious drugs and investigation skills in Delhi |
Pharmabiz |
India |
|
19 |
27 05 2026 |
Beauty through Syringes No longer Cosmetic : Glutathione drips, injectable Aesthetic procedures under CDSCO lens |
Medical Dialogues |
India |
|
20 |
26 05 2026 |
Strengthened regulatory oversight & uncompromising quality standards anchor India’s surging global pharma footprint |
Pharmabiz |
India |
